Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Clinical studies on SM-4300].

Y Sawae, S Nagafuchi

    The Japanese Journal of Antibiotics
    |September 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    SM-4300, a new intravenous immunoglobulin, showed 40% efficacy in treating severe bacterial infections in 13 patients, including those with leukemia and pneumonia. No adverse reactions were observed, suggesting its potential as an adjunctive therapy.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Simple and efficient chemosensitivity assay for human primary tumor-cells using contact-sensitive microtiter plates.

    International journal of oncology·2011
    Same author

    Influence of microscopic surface asperities on the wear of ultra-high molecular weight polyethylene in a knee prosthesis.

    Proceedings of the Institution of Mechanical Engineers. Part H, Journal of engineering in medicine·2010
    Same author

    Effects of dietary uridine 5'-monophosphate on immune responses in newborn calves.

    Journal of animal science·2009
    Same author

    Recurrent herpes simplex virus infection in a patient with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy associated with L29P and IVS9-1G>C compound heterozygous autoimmune regulator gene mutations.

    Journal of internal medicine·2007
    Same author

    Elasto-plastic contact analysis of an ultra-high molecular weight polyethylene tibial component based on geometrical measurement from a retrieved knee prosthesis.

    Proceedings of the Institution of Mechanical Engineers. Part H, Journal of engineering in medicine·2004
    Same author

    Dietary fructooligosaccharides up-regulate immunoglobulin A response and polymeric immunoglobulin receptor expression in intestines of infant mice.

    Clinical and experimental immunology·2004
    Same journal

    Evaluation of rapid measurement of Chlamydia trachomatis and Neisseria gonorrhoeae by using automatic gene analyzer "GENECUBE".

    The Japanese journal of antibiotics·2018
    Same journal

    Investigations on yearly changes in tebipenem susceptibility of bacterial isolates from pediatric patients -A post-marketing surveillance of tebipenem pivoxil granules for pediatric.

    The Japanese journal of antibiotics·2018
    Same journal

    Clinical analysis of the pediatric inpatients with lower respiratory tract infection due to human metapneumovirus.

    The Japanese journal of antibiotics·2018
    Same journal

    Historical and hygienic aspects on roles of quality requirements for antibiotic products in Japan: Part 5 - Introduction of technology and knowledge on streptomycin production from the United States of Americat.

    The Japanese journal of antibiotics·2018
    Same journal

    Historical and hygienic aspects on roles of quality requirements for antibiotic products in Japan: Part 4 - Enactment of requirements for individual antibiotic products.

    The Japanese journal of antibiotics·2018
    Same journal

    Visual disturbance or central symptom like hallucination in patients treated voriconazole: report of six cases.

    The Japanese journal of antibiotics·2018
    See all related articles

    Area of Science:

    • Immunology
    • Pharmacology
    • Infectious Diseases

    Context:

    • Severe and intractable bacterial infections pose significant clinical challenges.
    • Patients with underlying conditions like hematologic malignancies (acute myelocytic leukemia, multiple myeloma) and lung diseases are particularly vulnerable.
    • Intravenous immunoglobulin preparations are explored for their immunomodulatory and antimicrobial-enhancing properties.

    Purpose:

    • To evaluate the clinical efficacy and safety of SM-4300, a novel human immunoglobulin preparation, in patients with severe or intractable bacterial infections.
    • To assess the treatment outcomes in a cohort of patients with diverse underlying conditions and infections.
    • To determine the potential role of SM-4300 as an adjunct to conventional antibiotic therapy.

    Summary:

    Related Experiment Videos

    • A clinical evaluation of SM-4300 was conducted in 13 patients with severe bacterial infections, including pneumonia, prosthetic valve endocarditis, cholecystitis with pericarditis, and fever of undetermined origin.
    • Patients received SM-4300 (5 g single bolus or 2.5 g daily for 3 days) in conjunction with pre-administered chemotherapy.
    • An overall efficacy rate of 40% was observed (good in 4, fair in 4), with no reported side reactions or significant changes in clinical variables. Bacteriological outcomes were largely unknown.
    • The study included patients with acute myelocytic leukemia, multiple myeloma, lung cancer, and bronchiectasis, highlighting the treatment of complex cases.

    Impact:

    • SM-4300 demonstrates potential utility in managing difficult-to-treat bacterial infections, particularly when used alongside antibiotics.
    • The favorable safety profile suggests SM-4300 can be considered for patients with compromised immune systems or severe infections.
    • Further research may elucidate optimal dosing strategies and expand the application of SM-4300 in critical care settings.